IQVIA (NYSE:IQV) Shares Unloaded by Rep. Kevin Hern

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of IQVIA Holdings Inc. (NYSE:IQV). In a filing disclosed on September 25th, the Representative disclosed that they had sold between $15,001 and $50,000 in IQVIA stock on September 14th. The trade occurred in the Representative’s “HERN FAMILY FOUNDATION” account.

Representative Kevin Hern also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of CenterPoint Energy (NYSE:CNP) on 9/15/2026.
• Sold $1,001 – $15,000 in shares of TJX Companies (NYSE:TJX) on 9/15/2026.
• Sold $15,001 – $50,000 in shares of STERIS (NYSE:STE) on 9/15/2026.
• Sold $1,001 – $15,000 in shares of Seagate Technology (NASDAQ:STX) on 9/15/2026.
• Sold $15,001 – $50,000 in shares of NextEra Energy (NYSE:NEE) on 9/14/2026.
• Sold $1,001 – $15,000 in shares of Marsh & McLennan Companies (NYSE:MRSH) on 9/14/2026.
• Sold $15,001 – $50,000 in shares of Home Depot (NYSE:HD) on 9/14/2026.
• Sold $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 9/14/2026.
• Sold $15,001 – $50,000 in shares of Emerson Electric (NYSE:EMR) on 9/14/2026.
• Sold $15,001 – $50,000 in shares of Devon Energy (NYSE:DVN) on 9/14/2026.

IQVIA Trading Up 0.2%

Shares of IQV stock opened at $271.01 on Tuesday. The company has a market cap of $44.61 billion, a P/E ratio of 33.62, a PEG ratio of 2.31 and a beta of 1.18. IQVIA Holdings Inc. has a fifty-two week low of $154.50 and a fifty-two week high of $277.40. The stock has a 50 day simple moving average of $250.32 and a two-hundred day simple moving average of $203.63. The company has a debt-to-equity ratio of 2.18, a quick ratio of 0.71 and a current ratio of 0.71.

IQVIA (NYSE:IQV) last announced its quarterly earnings data on Tuesday, July 28th. The medical research company reported $3.15 EPS for the quarter, topping the consensus estimate of $3.03 by $0.12. The company had revenue of $4.37 billion during the quarter, compared to the consensus estimate of $4.30 billion. IQVIA had a net margin of 8.10% and a return on equity of 30.25%. The company’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the firm posted $2.81 EPS. IQVIA has set its FY 2026 guidance at 12.800-13.000 EPS. Research analysts forecast that IQVIA Holdings Inc. will post 11.56 earnings per share for the current year.

Insider Buying and Selling at IQVIA

In other news, insider Keriann Cherofsky sold 558 shares of the company’s stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $245.21, for a total value of $136,827.18. Following the completion of the transaction, the insider directly owned 2,989 shares of the company’s stock, valued at $732,932.69. This represents a 15.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider W. Richard Staub sold 5,500 shares of IQVIA stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $232.68, for a total value of $1,279,740.00. Following the sale, the insider owned 13,312 shares in the company, valued at $3,097,436.16. This trade represents a 29.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 15,581 shares of company stock valued at $3,796,021 in the last quarter. 1.70% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Stifel Nicolaus lifted their price target on shares of IQVIA from $220.00 to $276.00 and gave the company a “buy” rating in a research note on Wednesday, July 29th. William Blair upgraded IQVIA to a “strong-buy” rating in a research note on Tuesday, July 28th. Morgan Stanley upped their price target on IQVIA from $240.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Thursday, September 17th. Wall Street Zen raised IQVIA from a “hold” rating to a “buy” rating in a research note on Saturday, September 12th. Finally, Royal Bank Of Canada upped their target price on IQVIA from $221.00 to $247.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 29th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $253.25.

Hedge Funds Weigh In On IQVIA

Several large investors have recently added to or reduced their stakes in IQV. QRG Capital Management Inc. increased its holdings in IQVIA by 87.7% during the 2nd quarter. QRG Capital Management Inc. now owns 58,407 shares of the medical research company’s stock worth $11,285,000 after purchasing an additional 27,283 shares in the last quarter. Envestnet Portfolio Solutions Inc. lifted its stake in IQVIA by 3.7% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 4,872 shares of the medical research company’s stock valued at $941,000 after acquiring an additional 174 shares in the last quarter. National Pension Service boosted its holdings in IQVIA by 6.6% during the 2nd quarter. National Pension Service now owns 375,973 shares of the medical research company’s stock worth $72,646,000 after acquiring an additional 23,411 shares during the last quarter. WINTON GROUP Ltd bought a new stake in shares of IQVIA in the 2nd quarter worth $5,046,000. Finally, Engineers Gate Manager LP bought a new position in shares of IQVIA during the second quarter valued at about $632,000. Institutional investors own 89.62% of the company’s stock.

About Representative Hern

Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma’s 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027.

Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma’s 1st Congressional District. He declared candidacy for the 2026 election.

Kevin Hern went into business as a McDonald’s franchisee in 1999. He acquired 10 McDonald’s franchises by 2012. He served on the McDonald’s National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.

About IQVIA

IQVIA Holdings Inc (NYSE: IQV) is a global provider of technology, analytics and contract research services for the life sciences industry. The company helps pharmaceutical, biotechnology and medical device organizations develop products, manage clinical trials, understand healthcare markets and improve commercial performance.

IQVIA’s offerings include clinical research and trial management, real-world data and evidence, healthcare analytics, technology platforms, consulting, and commercial services such as sales support and patient engagement.